Founded in 2021, Tracer is a pioneering start-up company dedicated to revolutionising the Australian Nuclear Medicine industry by stabilising the radiopharmaceutical supply chain. Recognising the critical role of radiopharmaceuticals in diagnosing and treating various medical conditions, Tracer has embarked on a mission to address the challenges associated with supply chain disruptions and shortages in Australia. Leveraging innovative technologies and strategic partnerships, Tracer aims to establish a robust and sustainable infrastructure for the production, distribution, and delivery of radiopharmaceuticals across the country. By ensuring reliable access to essential radiotracers for medical imaging and therapy, Tracer seeks to enhance patient care, support clinical research initiatives, and drive advancements in nuclear medicine practice in Australia and beyond.
